DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting
BROSSARD, Quebec, June 12, 2026 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, announces a grant of an aggregate number of 1,500,000 stock options to directors and officers of the Corporation. The […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.